An Extension Study for Patients Previously Treated With ARQ 501

NCT00622063 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
1
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)